Polaris Venture Management Co. V as of Sept. 30, 2015
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Trevena | 18.8 | $28M | 2.7M | 10.35 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 12.8 | $19M | 1.8M | 10.26 | |
| Pulmatrix | 12.1 | $18M | 3.6M | 4.91 | |
| T2 Biosystems | 12.1 | $18M | 2.0M | 8.76 | |
| Ocular Therapeutix (OCUL) | 11.8 | $17M | 1.2M | 14.06 | |
| Genocea Biosciences | 9.2 | $14M | 2.0M | 6.85 | |
| Fate Therapeutics (FATE) | 9.0 | $13M | 2.5M | 5.33 | |
| Cerulean Pharma | 8.2 | $12M | 3.3M | 3.66 | |
| Bind Therapeutics | 6.1 | $9.0M | 2.0M | 4.46 |
